BRIEF-Anika Therapeutics announces Canadian launch of cingal
May 19 (Reuters) - Anika Therapeutics Inc
* Announces Canadian launch of cingal for the treatment of pain associated with osteoarthritis of the knee
* Cingal will be marketed and sold in Canada by Pendopharm, a division of Pharmascience Inc, a Quebec-based pharmaceutical company Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
© Thomson Reuters 2017 All rights reserved.